Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs)

The diagnosis of pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis, in particular, when patients present with unresectable disease. While significant progress has been made in understanding the biology of PDAC, this knowledge has not translated into a clear clinical benefit and curr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Med Sci (Basel)
Main Authors: Renz, Bernhard W., D’Haese, Jan G., Werner, Jens, Westphalen, C. Benedikt, Ilmer, Matthias
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2017
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5635789/
https://ncbi.nlm.nih.gov/pubmed/29099030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medsci5020014
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki